Future biotechnology drugs in protease therapy may include allosteric-site interactors ... other biologicals such as antibodies. They are catalytic and can therefore be used in smaller amounts ...

“We have built a robust protease engineering platform that allows us to harness the catalytic power of nature’s key biological regulators through optimization and tuning of their ...